TWD 14.95
(-18.31%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 74.02 Million TWD | 55.1% |
2022 | 47.72 Million TWD | 9.72% |
2021 | 43.5 Million TWD | -2.94% |
2020 | 44.81 Million TWD | 174.07% |
2019 | -60.5 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 FY | 74.02 Million TWD | 55.1% |
2022 FY | 47.72 Million TWD | 9.72% |
2021 FY | 43.5 Million TWD | -2.94% |
2020 FY | 44.81 Million TWD | 174.07% |
2019 FY | -60.5 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -22399.392% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 42.02% |
Level Biotechnology Inc. | 151.99 Million TWD | 51.298% |
Sagittarius Life Science Corp | 135.85 Million TWD | 45.512% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 2.42% |
TaiMed Biologics Inc. | 225.23 Million TWD | 67.135% |
GlycoNex Incorporation | 995 Thousand TWD | -7339.497% |
VBI | 32.55 Million TWD | -127.378% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 71.183% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 61.88% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -60.839% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 38.268% |
Visgeneer Inc. | 67.48 Million TWD | -9.693% |
Mycenax Biotech Inc. | -375.19 Million TWD | 119.729% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 85.488% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -15.837% |
Neith Corporation | 66.87 Million TWD | -10.692% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 94.874% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -152.191% |
Enimmune corporation | 220.1 Million TWD | 66.369% |
TaiRx, Inc. | 217.13 Million TWD | 65.909% |
CHO Pharma, Inc. | 268.99 Million TWD | 72.482% |
EirGenix Inc. | 236.74 Million TWD | 68.732% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 29.063% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 79.301% |
Lin BioScience, Inc. | 1.09 Billion TWD | 93.251% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 72.188% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -49.629% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -6734.995% |
Lukas Biomedical Inc. | 177.45 Million TWD | 58.285% |
RBC Bioscience Corporation | 58.35 Million TWD | -26.847% |
BiOptic Inc. | 108.69 Million TWD | 31.897% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -82147.778% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -6.738% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -2730.707% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 88.504% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 20.692% |
NaviFUS Corp. | 11.82 Million TWD | -525.881% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 61.189% |
Sinew Pharma Inc. | 186.25 Million TWD | 60.257% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 66.414% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -78.45% |
AP Biosciences Inc | 32.25 Million TWD | -129.507% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 96.0% |
3D Global Biotech Inc. | 5.27 Million TWD | -1303.546% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 76.673% |
Intech Biopharm Corporation | -163.99 Million TWD | 145.137% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 93.445% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -78.446% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 56.343% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 49.652% |
TCI GENE Inc. | 174.61 Million TWD | 57.608% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -411138.889% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 75.403% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 74.559% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 11.82% |
PharmaEngine, Inc. | 441.78 Million TWD | 83.245% |
Savior Lifetec Corporation | 223.36 Million TWD | 66.861% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 71.395% |
OBI Pharma, Inc. | 2.01 Billion TWD | 96.329% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 46.696% |
Acepodia, Inc. | 452.56 Million TWD | 83.644% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 86.316% |